04.08.2017 News
Oppenhoff & Partner advises Siemens Healthineers on the sale of its ELISA Immunodiagnostics Business to DiaSorin
Oppenhoff & Partner has advised Siemens Healthineers on the sale of its ELISA immunodiagnostics business to DiaSorin (Saluggia, Italy).
The sale includes Siemens’ customer's sales and distribution contracts regarding enzyme-linked immunosorbent assays (ELISA), the installed instrument base, as well as relevant intellectual property. The transaction is expected to be completed in the second half of 2017.
Siemens Healthineers is a worldwide healthcare provider specializing in medical imaging and laboratory diagnostics, technologies for therapeutic and molecular diagnostics as well as adding managed services, consulting, and healthcare IT services. Siemens will continue to exclusively manufacture and provide to DiaSorin its ELISA immunodiagnostic reagent kits for up to three years.
The Oppenhoff team comprised Ronald Meißner, Katharina Leoff (Corporate/M&A) and Jörn Kuhn (Employment Law).
The Siemens in-house team comprised Christoph Scholz, Dr. Christian Kirschke (both Legal M&A) and Tobias Thäns (Legal Business).
Oppenhoff & Partner stands for more than 100 years of top quality legal advice. Our independent law firm extensively advises national and international enterprises and entrepreneurs on matters of commercial and tax law.